TransMedics Group, Inc. Stock price

Equities

TMDX

US89377M1099

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
73.94 USD -0.24% Intraday chart for TransMedics Group, Inc. -0.05% -6.32%
Sales 2024 * 367M Sales 2025 * 490M Capitalization 2.42B
Net income 2024 * -1M Net income 2025 * 16M EV / Sales 2024 * 7.11 x
Net Debt 2024 * 188M Net Debt 2025 * 205M EV / Sales 2025 * 5.35 x
P/E ratio 2024 *
-1,043 x
P/E ratio 2025 *
165 x
Employees 584
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.24%
1 week-0.05%
Current month-9.39%
1 month-9.83%
3 months-8.81%
6 months+30.24%
Current year-6.32%
More quotes
1 week
69.43
Extreme 69.43
78.79
1 month
69.43
Extreme 69.43
90.21
Current year
69.43
Extreme 69.43
92.63
1 year
36.42
Extreme 36.4201
99.63
3 years
10.00
Extreme 10
99.63
5 years
10.00
Extreme 10
99.63
10 years
10.00
Extreme 10
99.63
More quotes
Managers TitleAgeSince
Founder 55 98-07-31
Director of Finance/CFO 56 15-02-28
Chief Tech/Sci/R&D Officer - 06-02-28
Members of the board TitleAgeSince
Chairman 79 10-12-31
Director/Board Member 67 02-12-31
Director/Board Member 68 20-12-31
More insiders
Date Price Change Volume
24-03-28 73.94 -0.24% 877,709
24-03-27 74.12 -0.50% 596,098
24-03-26 74.49 +4.81% 813,387
24-03-25 71.07 +0.30% 708,641
24-03-22 70.86 -4.22% 993,239

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
73.94 USD
Average target price
100.3 USD
Spread / Average Target
+35.70%
Consensus
  1. Stock
  2. Equities
  3. Stock TransMedics Group, Inc. - Nasdaq